2022年1月
Nivolumab monotherapy after induction chemotherapy, bioradiotherapy, and cetuximab monotherapy leading to complete remission of locoregional advanced tongue cancer: A case report
ORAL SCIENCE INTERNATIONAL
- ,
- ,
- ,
- ,
- ,
- 巻
- 19
- 号
- 1
- 開始ページ
- 72
- 終了ページ
- 76
- 記述言語
- 英語
- 掲載種別
- 研究論文(学術雑誌)
- DOI
- 10.1002/osi2.1114
- 出版者・発行元
- WILEY
Herein, we report on a 66-year-old woman with locoregional advanced tongue cancer. She was diagnosed with left side tongue carcinoma and achieved complete remission using nivolumab monotherapy after induction chemotherapy (IC) with docetaxel, cisplatin, and 5-fluorouracil, followed by intensity-modulated bioradiotherapy and cetuximab monotherapy. Following bioradiotherapy, she was administered 70 cycles of cetuximab monotherapy. Both IC and bioradiotherapy exerted antitumor effects. However, primary tumor recurrence occurred. She received nivolumab, and the recurrent lesion disappeared after 18 cycles. She has been alive and well for >5 years, showing a successful locoregional control for advanced tongue cancer during this period.
- リンク情報
-
- DOI
- https://doi.org/10.1002/osi2.1114
- Web of Science
- https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000655917700001&DestApp=WOS_CPL
- Scopus
- https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85106728058&origin=inward
- Scopus Citedby
- https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85106728058&origin=inward
- ID情報
-
- DOI : 10.1002/osi2.1114
- ISSN : 1348-8643
- eISSN : 1881-4204
- SCOPUS ID : 85106728058
- Web of Science ID : WOS:000655917700001